MB Therapeutics expands its leadership team
With the goal of enhancing its production capabilities under GMP conditions, combined with pharmaceutical 3D printing technology, MB Therapeutics is excited to announce the addition of Damien Stefanelli to its leadership team.
Expertise in pharmaceutical operational excellence
With over 20 years of experience in the pharmaceutical industry (Ipsen, MedinCell, Skyepharma, etc.), Damien Stefanelli brings deep expertise in Lean Six Sigma, international project management, and pharmaceutical quality.
He has held various strategic roles, including international project manager, head of quality assurance and control, quality auditor, batch release, as well as qualifications/validation, development, scale-up, and manufacturing transfer on sites inspected by the US FDA, ANSM, and ANVISA.
In addition to his operational responsibilities, Damien is also a trainer for CEFIRA and the Faculty of Pharmacy of Montpellier, and serves as an expert in Quality by Design as a member of GIC A3P QbD.
With his comprehensive experience and sharp understanding of technical and regulatory constraints, his expertise aligns perfectly with MB Therapeutics’ ambitions.
A Mission to Accomplish
Joining the MB Therapeutics team is not just an incredibly inspiring and rewarding human adventure; it’s a shared mission to put innovation and operational excellence at the service of the patient. I would like to thank Stéphane (CEO) and Ian (CTO), the founders of the startup, for their trust.
By integrating Damien Stefanelli into the executive team and management committee, MB Therapeutics reaffirms its ambition to offer pharmaceutical inks manufactured at its own GMP-certified facility.
Conclusion
The recruitment of Damien Stefanelli as Chief Operating Officer (COO) strengthens MB Therapeutics’ commitment to the production of personalized medications through pharmaceutical 3D printing.
With his international experience, Lean Six Sigma project management skills, and exceptional personal qualities, Damien is stepping into a strategic role that will enable him to leverage his expertise and network to advance the company’s mission: revolutionizing personalized medicine with cutting-edge technology.
